EXPERIENCE OF THE NATIONAL VACCINATION PROGRAM IMPLEMENTATION AGAINST HUMAN PAPILLOMA VIRUS IN THE REPUBLIC OF UZBEKISTAN

dc.contributor.authorN.N. Zakhirova
dc.contributor.authorM.N. Tillyashaykhov
dc.contributor.authorA.A. Adylkhodjaev
dc.contributor.authorO.M. Akhmedov
dc.contributor.authorE.Z. Osmanova
dc.contributor.authorV.A.Saydakhmedova
dc.contributor.authorN.M Raximov
dc.date.accessioned2025-12-31T15:36:21Z
dc.date.issued2022-08-21
dc.description.abstractCervical cancer is one of the most serious threats to women's health. This is the fourth most common cancer in women around the world. According to the forecasts of international experts (taking into account population growth and an increase of life span expectancy), the increase in the incidence and prevalence of cervical cancer will have made up 40% in developing countries and in economically developed countries - 11% by 2020. In the case of nonconducting timely measures for the prevention and treatment of cervical cancer, malignant neoplasms of the cervix will affect up to 1 million women annually after 2050 in the world
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/1276
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/49045
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/1276/1150
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 13 (2022): WBPH; 126-131
dc.source2749-3644
dc.subjectVaccination
dc.subjectcervical cancer
dc.subjectprimary
dc.subjectpapillomavirus
dc.titleEXPERIENCE OF THE NATIONAL VACCINATION PROGRAM IMPLEMENTATION AGAINST HUMAN PAPILLOMA VIRUS IN THE REPUBLIC OF UZBEKISTAN
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
zakhirova_2022_experience_of_the_national_vaccination_p.pdf
item.page.filesection.size
428.94 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections